Most people on Ozempic lose around 6% of their body weight within three months and roughly 11% by six months. For someone starting at 220 pounds, that translates to about 13 pounds in three months and 24 pounds by six months. But results vary widely: some people lose far more, others barely budge, and your dose, starting weight, and whether you have diabetes all influence the outcome.
What the Numbers Look Like Over Time
A 2022 cohort study of 175 patients published in JAMA Network Open tracked real-world semaglutide users (semaglutide is the active ingredient in Ozempic). At three months, participants lost an average of 14.8 pounds, or 5.9% of their body weight. By six months, the average climbed to 27.1 pounds, or 10.9% of body weight. These were patients with overweight or obesity, many of whom were also making diet and exercise changes alongside the medication.
Longer-term data from the SELECT trial, which followed participants for four years, showed semaglutide produced an average weight reduction of 10.2% along with a waist circumference reduction of about three inches. That sustained loss over four years is notable because weight loss from most interventions tends to plateau or reverse well before that point.
Why Your Results May Differ
Not everyone responds to Ozempic the same way. Research categorizes users into three groups based on total body weight loss: non-responders (less than 5%), moderate responders (5% to 15%), and hyper-responders (more than 15%). In one large retrospective analysis, about 18% of participants were non-responders, 48% had a moderate response, and 34% were hyper-responders. So roughly one in three people loses more than 15% of their body weight, while nearly one in five sees minimal results.
People with type 2 diabetes consistently lose less weight on semaglutide than people without diabetes. This likely reflects differences in metabolism and the medications people with diabetes are already taking, some of which promote weight gain. If you’re using Ozempic primarily for blood sugar control, your weight loss may be more modest than the headline numbers suggest.
How Dose Affects Weight Loss
Ozempic is available in doses up to 2.0 mg per week, and the dose you’re on makes a measurable difference. In the SUSTAIN FORTE trial, participants on the 2.0 mg dose lost an average of 15.2 pounds over 40 weeks, compared to 13.2 pounds on the 1.0 mg dose. That’s about two extra pounds from the higher dose, a real but relatively modest gain.
Most people start Ozempic at 0.25 mg and gradually increase over several months. The slow ramp-up is designed to reduce nausea and other gastrointestinal side effects, which are the most common complaints. About a third of users at any dose report stomach-related issues. The weight loss benefit increases with each dose step, but so can the side effects, so many people settle at whatever dose they tolerate well rather than automatically pushing to the maximum.
Ozempic vs. Wegovy
Both Ozempic and Wegovy contain semaglutide, but Wegovy goes up to 2.4 mg per week compared to Ozempic’s 2.0 mg cap. Wegovy is also the only semaglutide product FDA-approved specifically for weight loss. In clinical trials at the 2.4 mg dose, 50% to 55% of participants lost more than 15% of their body weight. If your primary goal is weight loss rather than blood sugar management, Wegovy at its higher dose generally produces better results, though the difference between 2.0 mg and 2.4 mg is incremental rather than dramatic.
What Happens When You Stop
This is the part most people don’t want to hear. In the STEP 1 trial extension, participants who stopped semaglutide regained two-thirds of the weight they had lost within one year. On average, they regained 11.6 percentage points of body weight after stopping. So if you lost 30 pounds, you could expect to gain back roughly 20 of those pounds within a year of discontinuing the medication.
This pattern mirrors what happens with most obesity treatments. The medication works by reducing appetite and slowing digestion, and when you remove it, those biological signals return to baseline. Weight regain doesn’t mean the medication “failed.” It means obesity is a chronic condition that, for many people, requires ongoing treatment to maintain results. Some people use this information to plan for long-term use, while others focus on building diet and exercise habits during treatment that may help them retain more of the loss if they eventually stop.
Putting the Numbers in Perspective
A 5% to 10% reduction in body weight is the threshold where meaningful health improvements begin: lower blood pressure, better cholesterol, reduced strain on joints, and improved blood sugar control. Most Ozempic users hit that range within three to six months. The average person can expect to lose somewhere between 15 and 30 pounds over the first six months, with continued but slower loss beyond that point.
Your individual result depends on your starting weight, dose, whether you have diabetes, how your body responds to the drug, and what lifestyle changes you make alongside it. The one-in-three chance of being a hyper-responder is encouraging, but the roughly one-in-five chance of minimal response is worth knowing about too, especially given the cost and commitment involved.